PRLD
Prelude Therapeutics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$3.30
-0.07 ▼ -2.08%
🌙 3월 13일 4:10 PM ET (한국 3/14 05:10)
$3.30
+0.00 +0.00%
| Index | - | P/E | - | EPS (ttm) | -1.35 | Insider Own | 64.47% | Shs Outstand | 0.05B | Perf Week | 2.17% |
| Market Cap | 0.19B | Forward P/E | - | EPS next Y | 54.29% | Insider Trans | - | Shs Float | 0.02B | Perf Month | 57.89% |
| Enterprise Value | 0.11B | PEG | - | EPS next Q | -0.24 | Inst Own | 30.08% | Short Float | 10.93% | Perf Quarter | 100% |
| Income | -0.10B | P/S | 15.9 | EPS this Y | 45.74% | Inst Trans | 3.36% | Short Ratio | 5.15 | Perf Half Y | 172.73% |
| Sales | 0.01B | P/B | 3.03 | EPS next 5Y | - | ROA | -62.81% | Short Interest | 2.27M | Perf YTD | 13.79% |
| Book/sh | 1.09 | P/C | 1.87 | EPS past 3/5Y | 19.05% 0.15% | ROE | -99.45% | 52W High | -21.8% ($4.22) | Perf Year | 366.83% |
| Cash/sh | 1.76 | P/FCF | - | Sales past 3/5Y | - | ROIC | -118.9% | 52W Low | 440.89% ($0.61) | Perf 3Y | -44.07% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 25.62% | Gross Margin | 85.91% | Volatility(W/M) | 15.02% 13.47% | Perf 5Y | -94.25% |
| Dividend TTM | - | EV/Sales | 8.86 | Sales Y/Y TTM | 73.43% | Oper. Margin | -861.33% | ATR (14) | 0.35 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.99 | EPS Q/Q | 49.83% | Profit Margin | -819.59% | RSI (14) | 59.12 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.99 | Sales Q/Q | 41% | SMA20 | 14.27% ($2.89) | Beta | 0.78 | Target Price | $5.25 |
| Payout | - | Debt/Eq | 0.26 | Earnings | 3000000 | SMA50 | 32.61% ($2.49) | Rel Volume | 0.56 | Prev Close | $3.37 |
| Employees | 79 | LT Debt/Eq | 0.22 | EPS/Sales Surpr. | -566.67% -72.68% | SMA200 | 109.4% ($1.58) | Avg Volume(3M) | 0.44M | Price | $3.3 |
| IPO | 2020/9/25 | Option/Short | Yes/Yes | Trades | 2203 | Volume | 245,625 | Change | -2.08% |
뉴스 로딩 중...